What is the latest price of evantumumab in 2024?

The latest price of evantumumab in 2024 will be around 10,300$ per box. The U.S. FDA approved evantumumab from Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson Group, on May 21, 2021, for the treatment of adult non-small cell lung cancer. It is suitable for patients carrying EGFR exon 20 insertion mutations. This is the first targeted drug approved by the FDA for the treatment of non-small cell lung cancer.

The latest price of evantuzumab in 2024

is relatively expensive. There are currently no generic drugs on the market. The price of the drug produced by American pharmaceutical companies is around $13,200.

1. The latest price of the drug: The price of evantumumab 350mg/7ml from Janssen Pharmaceuticals in the United States is 13,200$ per box.

2. The marketing status of evantumumab in China: According to the announcement on the official website of the Center for Drug Evaluation (CDE) of the China State Food and Drug Administration on January 26, 2024, the marketing application of evantumumab in China has been accepted. Previously, the drug has been approved in the United States for the treatment of NSCLC patients with EGFR exon 20 insertion mutations, and has been included by CDE as a breakthrough therapy for the treatment of specific NSCLC. The drug is expected to be officially launched in China in the near future, providing a new treatment option for NSCLC patients carrying specific gene mutations.

3. Domestic sales: Evantumumab has been launched in Taiwan and Hong Kong, but has not been launched in mainland China so far. Therefore, patients can buy this drug in hospitals or pharmacies in Taiwan or Hong Kong, but they cannot buy it in pharmacies in mainland China.

4. Drug purchase channels: Evantumumab has not yet been officially launched in China, so patients cannot directly purchase Evantumumab in hospitals in mainland China. Some medical service institutions or multinational medical platforms may provide purchase services for evantumumab, and patients in need can make relevant consultations to learn about formal purchase channels.

Warm reminder: It should be noted that evantuzumab is a prescription drug. No matter how you purchase evantuzumab, patients should first go to the hospital for treatment. The doctor will issue a prescription after examination and hold the prescription to purchase the drug. After purchasing the medicine, you should strictly follow the doctor's instructions and do not use it privately to avoid improper use of medicine that may endanger your health.